Tatva Chintan Pharma Chem Balance Sheet
- Market cap
- ₹4,194 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,290.82 – ₹2,420.28
As of FY25, Tatva Chintan Pharma Chem had total assets of ₹2,726 crore and borrowings of ₹503 crore, against shareholders' equity of ₹2,007 crore — a debt-to-equity ratio of 0.35.
Tatva Chintan Pharma Chem balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 1,887 |
| Borrowings | 503 |
| Other liabilities | 336 |
| Total liabilities | 2,726 |
| Fixed assets | 1,468 |
| Capital work in progress | 45 |
| Investments | 629 |
| Other assets | 629 |
| Total assets | 2,726 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹629.05
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Tatva Chintan Pharma Chem balance sheet — frequently asked questions
What is the total debt of Tatva Chintan Pharma Chem?
Tatva Chintan Pharma Chem reported borrowings of ₹503 crore as of FY25.
What is Tatva Chintan Pharma Chem's debt-to-equity ratio?
Based on the FY25 balance sheet, Tatva Chintan Pharma Chem's debt-to-equity ratio is 0.35 — borrowings of ₹503 crore against equity capital and reserves of ₹2,007 crore.
What are Tatva Chintan Pharma Chem's total assets?
Tatva Chintan Pharma Chem's total assets were ₹2,726 crore as of FY25, including fixed assets of ₹1,468 crore and investments of ₹629 crore.
What is the book value per share of Tatva Chintan Pharma Chem?
The book value per share of Tatva Chintan Pharma Chem is ₹629.05, based on the latest reported balance sheet.
Same Data For Peers
Trade Tatva Chintan Pharma Chem With ATS
Track TATVA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.